Following the recent publication of the PRAMI trial, the appearance of the article entitled ‘‘Multivessel approach in ST-elevation myocardial infarction: Impact on in-hospital morbidity and mortality’’ by Santos et al. in this issue of the Journal could not be more timely. The study analyzed a population of patients with ST-elevation myocardial infarction (STEMI) included in the Portuguese Regi...

Little information is currently available from the various societies of cardiology on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Since primary PCI is the main method of reperfusion in AMI in many centres, and since of all cardiac emergencies AMI represents the most urgent situation for PCI, recommendations based on scientific evidence and expert expe...

background: the aim of the present study was to develop a scoring system for predicting 1-year major adverse cardiac events (mace), including mortality, target vessel or target lesion revascularization, coronary artery bypass graft surgery, and non-fatal myocardial infarction after percutaneous coronary intervention (pci). methods: the data were extracted from a single center pci registry. the ...

Developers of systems to improve access to primary percutaneous intervention (PCI) must recognize that most ST-elevation myocardial infarction (STEMI) patients present to hospitals that do not have PCI capability. Indeed, only 25% of US hospitals are currently capable of delivering this intervention.1 These non–PCI-capable institutions are often located in rural areas and face real challenges r...

For patients with ST-segment–elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PCI) is superior to fibrinolytic therapy if primary PCI is performed (1) in a timely manner with a door-toballoon time 90 minutes; (2) by experienced operators and PCI hospitals; (3) and for patients who have high clinical risk, high bleeding risk, or delays in presentation from sym...

BACKGROUND Primary percutaneous coronary intervention (PCI) is at present the most effective procedure for reducing the mortality rate of patients with acute myocardial infarction (AMI). However, there is a great difference between Japan and other countries in the rate of primary PCI. METHODS AND RESULTS Registration period, number of patients with AMI, rates of primary PCI or thrombolysis an...

Mortality rates for acute ST-segment–elevation myocardial infarction (STEMI) have improved dramatically over the past 3 decades: effective reperfusion therapy has been the cornerstone of this improvement, with recent trends showing growth in primary percutaneous coronary intervention (PCI). Although mortality rates for routine risk STEMI patients are now ≈5%, process and procedure challenges re...